Proportion of isolates with decreased susceptibility or resistance in New Zealand
New Zealand: Proportion of isolates with decreased susceptibility or resistance was 0.4386 in 2017. ◆ Volatile
Latest (2017)
0.4386
Change on year
up 58.3%
World rank
22nd
of 51 countries
All-time high
1.04
in 2013
All-time low
0
in 2009
Years of data
9
2009–2017
Proportion of isolates with decreased susceptibility or resistance in New Zealand, 2009–2017
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for proportion of isolates with decreased susceptibility or resistance in New Zealand is 0.4386, measured in 2017.
The figure is up 58.3% on the previous year.
Over the whole period, proportion of isolates with decreased susceptibility or resistance in New Zealand peaked at 1.04 in 2013 and was at its lowest, 0, in 2009.
That places New Zealand 22nd out of 51 countries with data for 2017, putting it in the middle of the range.
Proportion of isolates with decreased susceptibility or resistance in New Zealand, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 0 | — |
| 2010 | 0 | — |
| 2011 | 0 | — |
| 2012 | 0 | — |
| 2013 | 1.04 | — |
| 2014 | 0.2309 | -77.8% |
| 2015 | 0.8881 | +284.5% |
| 2016 | 0.277 | -68.8% |
| 2017 | 0.4386 | +58.3% |
New Zealand compared with similar countries
- New Zealand's 0.4386 is above the median for high income countries, which is 0.0666, 6.6× the median. (33 countries reporting)
- New Zealand's 0.4386 is below the median for East Asia & Pacific, which is 1.14, 39% of the median. (10 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0 | 0 | 0 | 1 |
| 2010s | 0.3595 | 0 | 1.04 | 8 |
Countries ranked near New Zealand
- 19 Mongolia 0.7752 compare
- 20 Canada 0.5445 compare
- 21 Thailand 0.4587 compare
- 23 United States of America 0.2907 compare
- 24 Australia 0.0666 compare
- 25 Cuba 0
- 25 Norway 0 compare
- 25 Slovakia 0 compare
- 25 France 0 compare
- 25 Colombia 0
- 25 Paraguay 0
- 25 Malta 0 compare
- 25 South Africa 0
- 25 Netherlands 0 compare
- 25 Slovenia 0 compare
- 25 Argentina 0 compare
- 25 Côte d'Ivoire 0
- 25 Russian Federation 0
- 25 Bhutan 0 compare
- 25 Portugal 0 compare
- 25 Estonia 0
- 25 Dominican Republic 0
- 25 Latvia 0 compare
- 25 Pakistan 0 compare
- 25 Peru 0 compare
- 25 Chile 0
- 25 Iceland 0
- 25 Denmark 0 compare
- 25 Panama 0
- 25 Ireland 0 compare
- 25 Sri Lanka 0
- 25 Korea 0 compare
More health data for New Zealand
- Un projection of annual infant deaths, annual growth rate -2.94 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.4815 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,116 deaths per 1,000 people (2090)
- Number of infants who die before age 1 33 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.1187 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0277 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.018 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is proportion of isolates with decreased susceptibility or resistance in New Zealand?
- Proportion of isolates with decreased susceptibility or resistance in New Zealand was 0.4386 in 2017, according to World Health Organization, Global Health Observatory.
- What is the highest proportion of isolates with decreased susceptibility or resistance recorded in New Zealand?
- The highest recorded value was 1.04 in 2013.
- What is the lowest proportion of isolates with decreased susceptibility or resistance recorded in New Zealand?
- The lowest recorded value was 0 in 2009.
- How does New Zealand rank for proportion of isolates with decreased susceptibility or resistance?
- New Zealand ranks 22nd out of 51 countries with data for 2017.
- Where does this New Zealand data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 9 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).